|Day's Range||0.46 - 0.46|
|52 Week Range||0.46 - 0.46|
|PE Ratio (TTM)||-3.19|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Delivra Corp. announces the appointment of Ms. Louisa Greco, B.Ph., a pharmaceutical industry veteran, to the Company's Board of Directors. The Company also announces that Mr. David Mitchell has...
Delivra Corp. reported its financial results for the three months ended March 31, 2017. All figures are reported in CDN dollars , unless otherwise indicated. Delivra's financial statements are...
Delivra Corp. and ARA-Avanti Rx Analytics Inc. announced today a strategic partnership to develop a unique suite of standardized natural and medicinal products for the medical pain-related...